4/18/20184/18/2018
Cederquist represented the financing bank in connection with the acquisition, through a newly established joint venture between Starwood Capital Group and Oscar Properties Holding AB (publ), of Primus 1 at Lilla Essingen in Stockholm with a total of 42,000 light BTA from Vasakronan, the purchase price amounting to SEK 920 millions.
4/17/20184/17/2018
Cederquist represented the lenders in connection with Karo Pharma’s acquisition of a product portfolio with an aggregate value of MEUR 260 from the Danish pharmaceutical company LEO Pharma A/S.
4/17/20184/17/2018
Cederquist represented the lender in connection with D. Carnegie´s acquisition of 27 properties located in the Stockholm region, from Akelius, amounting to SEK 2,47 billion.
4/11/20184/11/2018
Cederquist is legal advisor to the US biopharmaceutical company Alexion Pharmaceuticals, Inc. (Alexion) in connection with Alexion’s public cash offer for the shares in Wilson Therapeutics AB that are listed on Nasdaq Stockholm.
3/27/20183/27/2018
Cederquist represents NDX Intressenter AB, a bidding vehicle jointly established by Nordic Capital Fund VIII and Sampo plc, in connection with its public cash offer for Nordax Group AB (publ.).
12/20/201712/20/2017
Cederquist represents Axel Johnson AB in its acquisition of 70% of the shares in Skincity Sweden AB from the Skincity’s founders Annica Forsgren Kjellman and Mikael Kjellman and Rite Internet Ventures Holding AB.
